{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:00:51Z","timestamp":1780977651653,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jbo.2026.100769","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:30:23Z","timestamp":1779676223000},"page":"100769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tenosynovial giant cell tumor of the hip: a systematic review and institutional case series with Meta-analysis of recurrence and patient-reported outcomes"],"prefix":"10.1016","volume":"58","author":[{"given":"E.","family":"van der Loos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.T.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.M.","family":"Bramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.W.B.","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.G.M.","family":"Verspoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2026.100769_bb0005","series-title":"WHO Classification of Tumours of Soft Tissue and Bone","article-title":"Tenosynovial giant cell tumour, diffuse type","volume":"4","author":"Somerhausen","year":"2013"},{"issue":"6","key":"10.1016\/j.jbo.2026.100769_bb0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.semarthrit.2010.07.005","article-title":"Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature","volume":"40","author":"Ottaviani","year":"2011","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jbo.2026.100769_bb0015","series-title":"Soft Tissue and Bone Tumours","author":"Tumours WCo","year":"2020"},{"issue":"6","key":"10.1016\/j.jbo.2026.100769_bb0020","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/17453674.2017.1361126","article-title":"Higher incidence rates than previously known in tenosynovial giant cell tumors","volume":"88","author":"Mastboom","year":"2017","journal-title":"Acta Orthop."},{"issue":"5","key":"10.1016\/j.jbo.2026.100769_bb0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/17453674.2016.1205168","article-title":"Arthroplasty for tenosynovial giant cell tumors","volume":"87","author":"Verspoor","year":"2016","journal-title":"Acta Orthop."},{"issue":"4","key":"10.1016\/j.jbo.2026.100769_bb0030","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.clinthera.2016.03.008","article-title":"Patient-reported symptoms of tenosynovial giant cell tumors","volume":"38","author":"Gelhorn","year":"2016","journal-title":"Clin. Ther."},{"issue":"7","key":"10.1016\/j.jbo.2026.100769_bb0035","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.RVW.15.00086","article-title":"Pigmented villonodular synovitis: a comprehensive review and proposed treatment algorithm","volume":"4","author":"Stephan","year":"2016","journal-title":"JBJS Rev."},{"issue":"3","key":"10.1016\/j.jbo.2026.100769_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121451","article-title":"Pigmented villonodular synovitis: a retrospective multicenter study of 237 cases","volume":"10","author":"Xie","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jbo.2026.100769_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.17161\/kjm.vol17.21831","article-title":"Pigmented villonodular synovitis: a critical review","volume":"17","author":"Bernard","year":"2024","journal-title":"Kans. J. Med."},{"issue":"5","key":"10.1016\/j.jbo.2026.100769_bb0050","doi-asserted-by":"crossref","first-page":"e1873","DOI":"10.1016\/j.asmr.2022.06.008","article-title":"Open or arthroscopic synovectomy is the preferred management option in pigmented Villonodular synovitis of the hip joint without evidence of degeneration: a systematic review of 20 studies","volume":"4","author":"Cheok","year":"2022","journal-title":"Arthrosc Sports Med Rehabil."},{"key":"10.1016\/j.jbo.2026.100769_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3072135","article-title":"Cryosurgery as additional treatment in tenosynovial giant cell tumors","volume":"2016","author":"Verspoor","year":"2016","journal-title":"Sarcoma"},{"issue":"3","key":"10.1016\/j.jbo.2026.100769_bb0060","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.prro.2022.11.004","article-title":"Long-term outcomes of diffuse or recurrent tenosynovial giant cell tumor treated with postoperative external beam radiation therapy","volume":"13","author":"Baniel","year":"2023","journal-title":"Pract. Radiat. Oncol."},{"issue":"6","key":"10.1016\/j.jbo.2026.100769_bb0065","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1470-2045(19)30100-7","article-title":"Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study","volume":"20","author":"Mastboom","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbo.2026.100769_bb0070","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"issue":"9","key":"10.1016\/j.jbo.2026.100769_bb0075","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J. Surg."},{"issue":"3","key":"10.1016\/j.jbo.2026.100769_bb0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"issue":"11","key":"10.1016\/j.jbo.2026.100769_bb0085","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008","volume":"63","author":"Cella","year":"2010","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.jbo.2026.100769_bb0090","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/01466216211013106","article-title":"PROsetta: an R package for linking patient-reported outcome measures","volume":"45","author":"Choi","year":"2021","journal-title":"Appl. Psychol. Meas."},{"key":"10.1016\/j.jbo.2026.100769_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00003086-200107000-00026","article-title":"Pigmented villonodular synovitis of the hip: 2- to 23-year followup study","volume":"388","author":"Gonz\u00e1lez Della Valle","year":"2001","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"4","key":"10.1016\/j.jbo.2026.100769_bb0100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00402-017-2864-y","article-title":"Long-term outcome of pigmented villonodular synovitis of the hip after joint preserving therapy","volume":"138","author":"Hufeland","year":"2018","journal-title":"Arch. Orthop. Trauma Surg."},{"issue":"6","key":"10.1016\/j.jbo.2026.100769_bb0105","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/os.13707","article-title":"Total hip arthroplasty or arthroscopy for pigmented villonodular synovitis of the hip: a retrospective study with 3-year follow-up at minimum","volume":"15","author":"Li","year":"2023","journal-title":"Orthop. Surg."},{"issue":"6","key":"10.1016\/j.jbo.2026.100769_bb0110","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00264-013-1858-9","article-title":"Pigmented villonodular synovitis: a retrospective study of seventy five cases (eighty one joints)","volume":"37","author":"Ma","year":"2013","journal-title":"Int. Orthop."},{"issue":"6","key":"10.1016\/j.jbo.2026.100769_bb0115","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.arthro.2020.01.059","article-title":"Mid-term results of arthroscopic synovectomy for pigmented Villonodular synovitis of the hip","volume":"36","author":"Nazal","year":"2020","journal-title":"Arthroscopy"},{"issue":"2","key":"10.1016\/j.jbo.2026.100769_bb0120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3899\/jrheum.110730","article-title":"Osteochondral destruction in pigmented villonodular synovitis during the clinical course","volume":"39","author":"Nishida","year":"2012","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.jbo.2026.100769_bb0125","doi-asserted-by":"crossref","first-page":"17384","DOI":"10.1038\/s41598-021-96795-6","article-title":"Tumor location and type affect local recurrence and joint damage in tenosynovial giant cell tumor: a multi-center study","volume":"11","author":"Ota","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jbo.2026.100769_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.52628\/89.1.10424","article-title":"Tenosynovial Giant Cell Tumor (TSGCT) of the hip: MRI accuracy and results of surgical treatment","volume":"89","author":"Schenk","year":"2023","journal-title":"Acta Orthop. Belg."},{"issue":"1","key":"10.1016\/j.jbo.2026.100769_bb0135","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12891-022-05141-y","article-title":"Clinical outcomes of endoscopic synovectomy with adjuvant radiotherapy of pigmented villonodular synovitis of the hip: a case series of single center","volume":"23","author":"Sun","year":"2022","journal-title":"BMC Musculoskelet. Disord."},{"issue":"10","key":"10.1016\/j.jbo.2026.100769_bb0140","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00402-021-04242-y","article-title":"Outcomes of arthroscopic management for pigmented villonodular synovitis of the hip","volume":"142","author":"Tang","year":"2022","journal-title":"Arch. Orthop. Trauma Surg."},{"issue":"5","key":"10.1016\/j.jbo.2026.100769_bb0145","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.arth.2017.12.030","article-title":"Long-term outcome of hip arthroplasty in the setting of pigmented villonodular synovitis","volume":"33","author":"Tibbo","year":"2018","journal-title":"J. Arthroplast."},{"issue":"5","key":"10.1016\/j.jbo.2026.100769_bb0150","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2106\/00004623-200505000-00012","article-title":"Surgical treatment of pigmented villonodular synovitis of the hip","volume":"87","author":"Vastel","year":"2005","journal-title":"JBJS"},{"issue":"3","key":"10.1016\/j.jbo.2026.100769_bb0155","doi-asserted-by":"crossref","DOI":"10.1177\/2325967118763118","article-title":"Arthroscopic management of pigmented villonodular synovitis of the hip in children and adolescents","volume":"6","author":"Willimon","year":"2018","journal-title":"Orthop. J. Sports Med."},{"issue":"16","key":"10.1016\/j.jbo.2026.100769_bb0160","article-title":"Efficacy and safety profile of pimicotinib (ABSK021) in tenosynovial giant cell tumor (TGCT): phase 1b update","volume":"41","author":"Xu","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.jbo.2026.100769_bb0165","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.arth.2009.02.015","article-title":"Cementless total hip arthroplasty performed in patients with pigmented villonodular synovitis","volume":"25","author":"Yoo","year":"2010","journal-title":"J. Arthroplast."},{"issue":"11","key":"10.1016\/j.jbo.2026.100769_bb0170","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.arthro.2013.08.002","article-title":"Two to 10 years\u2019 follow-up of arthroscopic management of pigmented villonodular synovitis in the hip: a case series","volume":"29","author":"Byrd","year":"2013","journal-title":"Arthroscopy"},{"issue":"7","key":"10.1016\/j.jbo.2026.100769_bb0175","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00590-018-2214-y","article-title":"Pigmented villonodular synovitis managed by total synovectomy and cementless total hip arthroplasty","volume":"28","author":"Elzohairy","year":"2018","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"issue":"1","key":"10.1016\/j.jbo.2026.100769_bb0180","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13018-018-0996-6","article-title":"Pigmented villonodular synovitis does not influence the outcome following cementless total hip arthroplasty using ceramic-on-ceramic articulation: a case-control study with middle-term follow-up","volume":"13","author":"Xu","year":"2018","journal-title":"J. Orthop. Surg. Res."},{"issue":"6","key":"10.1016\/j.jbo.2026.100769_bb0185","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.3928\/01477447-20251103-01","article-title":"The impact of osseous erosions on intraarticular tenosynovial giant cell tumors of the knee and local recurrence","volume":"48","author":"Olson","year":"2025","journal-title":"Orthopedics"},{"issue":"2","key":"10.1016\/j.jbo.2026.100769_bb0190","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/his.13744","article-title":"Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?","volume":"74","author":"Mastboom","year":"2019","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.jbo.2026.100769_bb0195","doi-asserted-by":"crossref","first-page":"e863","DOI":"10.1002\/onco.13629","article-title":"Pexidartinib long-term hepatic safety profile in patients with tenosynovial giant cell tumors","volume":"26","author":"Lewis","year":"2021","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.jbo.2026.100769_bb0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/14728222.2022.2067040","article-title":"Tenosynovial giant cell tumors (TGCT): molecular biology, drug targets and non-surgical pharmacological approaches","volume":"26","author":"Spierenburg","year":"2022","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221213742600031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221213742600031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:39:08Z","timestamp":1780976348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221213742600031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"alternative-id":["S221213742600031X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2026.100769","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tenosynovial giant cell tumor of the hip: a systematic review and institutional case series with Meta-analysis of recurrence and patient-reported outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2026.100769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100769"}}